M

Memphasys Ltd
ASX:MEM

Watchlist Manager
Memphasys Ltd
ASX:MEM
Watchlist
Price: 0.0045 AUD
Market Cap: 8.9m AUD
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

MEM doesn't have a meaningful market cap.

The Relative Value of one MEM stock under the Base Case scenario is 2.0E-5 AUD. Compared to the current market price of 0.0045 AUD, Memphasys Ltd is Overvalued by 100%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

MEM Relative Value
Base Case
2.0E-5 AUD
Overvaluation 100%
Relative Value
Price
M
Worst Case
Base Case
Best Case

Valuation Multiples

2 412.5
P/S
P/S
Price to Sales
2 412.5
vs History
7
vs Industry
0
Median 3Y
515.1
Median 5Y
447.6
Industry
3.9
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-2.8
Median 5Y
-6.7
Industry
31.2
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
16
Median 3Y
-4.7
Median 5Y
-3.7
Industry
21.4
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
-4
Median 5Y
-6.1
Industry
35.6
More Details
1.7
P/B
P/B
Price to Book Value
1.7
vs History
46
vs Industry
40
Median 3Y
1.7
Median 5Y
2.1
Industry
2.7
More Details
2 405.4
EV/S
EV/S
Enterprise Value to Sales
2 405.4
vs History
7
vs Industry
0
Median 3Y
645.7
Median 5Y
508
Industry
3.8
More Details
Negative
EV/GP
EV/GP
Enterprise Value to Gross Profit
N/A
vs History
vs Industry
1
Median 3Y
1 547.1
Median 5Y
615.9
Industry
8.5
More Details
Negative
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
N/A
vs History
vs Industry
Median 3Y
-4.2
Median 5Y
-10.5
Industry
18.5
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
Median 3Y
-4.2
Median 5Y
-10.5
Industry
23.2
More Details
Negative
EV/OCF
EV/OCF
Enterprise Value to OCF
N/A
vs History
vs Industry
11
Median 3Y
-5.5
Median 5Y
-3.9
Industry
20.7
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
Median 3Y
-4.2
Median 5Y
-5.9
Industry
27.6
More Details
0.9
EV/IC
EV/IC
Enterprise Value to IC
0.9
vs History
65
vs Industry
46
Median 3Y
1.1
Median 5Y
1.3
Industry
2.4
More Details

Multiples Across Competitors

MEM Competitors Multiples
Memphasys Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
AU
Memphasys Ltd
ASX:MEM
8.9m AUD 2 412.5 -1.8 -2.5 -2.5
US
PerkinElmer Inc
LSE:0KHE
957.9B USD 342.3 3 358.8 1 181.4 2 401.6
US
Thermo Fisher Scientific Inc
NYSE:TMO
181.3B USD 4.2 27.5 21.1 26.5
US
Danaher Corp
NYSE:DHR
139.5B USD 5.8 40.9 21.5 32.3
KR
Samsung Biologics Co Ltd
KRX:207940
71.2T KRW 14.1 55.3 31.1 43.5
CH
Lonza Group AG
SIX:LONN
38B CHF 5.4 51.8 37.8 37.8
CN
WuXi AppTec Co Ltd
SSE:603259
308.6B CNY 7.2 22.4 24.2 24.2
US
Agilent Technologies Inc
NYSE:A
36.3B USD 5.5 31.1 21 24.8
US
IQVIA Holdings Inc
NYSE:IQV
32.2B USD 2.1 26 13.1 19.5
US
Mettler-Toledo International Inc
NYSE:MTD
26.8B USD 6.9 32.3 23.5 26.1
FR
Sartorius Stedim Biotech SA
PAR:DIM
18B EUR 6.2 79.8 27.2 47.1
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
AU
M
Memphasys Ltd
ASX:MEM
Average EV/EBITDA: 140.2
Negative Multiple: -2.5 		N/A N/A
US
P
PerkinElmer Inc
LSE:0KHE
1 181.4
6%
196.9
US
Thermo Fisher Scientific Inc
NYSE:TMO
21.1
5%
4.2
US
Danaher Corp
NYSE:DHR
21.5
7%
3.1
KR
Samsung Biologics Co Ltd
KRX:207940
31.1
17%
1.8
CH
Lonza Group AG
SIX:LONN
37.8
18%
2.1
CN
WuXi AppTec Co Ltd
SSE:603259
24.2
24%
1
US
Agilent Technologies Inc
NYSE:A
21
10%
2.1
US
IQVIA Holdings Inc
NYSE:IQV
13.1
8%
1.6
US
Mettler-Toledo International Inc
NYSE:MTD
23.5
4%
5.9
FR
Sartorius Stedim Biotech SA
PAR:DIM
27.2
20%
1.4
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
AU
M
Memphasys Ltd
ASX:MEM
Average EV/EBIT: 268.3
Negative Multiple: -2.5 		N/A N/A
US
P
PerkinElmer Inc
LSE:0KHE
2 401.6
30%
80.1
US
Thermo Fisher Scientific Inc
NYSE:TMO
26.5
20%
1.3
US
Danaher Corp
NYSE:DHR
32.3
17%
1.9
KR
Samsung Biologics Co Ltd
KRX:207940
43.5
25%
1.7
CH
Lonza Group AG
SIX:LONN
37.8
22%
1.7
CN
WuXi AppTec Co Ltd
SSE:603259
24.2
19%
1.3
US
Agilent Technologies Inc
NYSE:A
24.8
15%
1.7
US
IQVIA Holdings Inc
NYSE:IQV
19.5
14%
1.4
US
Mettler-Toledo International Inc
NYSE:MTD
26.1
6%
4.4
FR
Sartorius Stedim Biotech SA
PAR:DIM
47.1
32%
1.5

See Also

Summary
MEM intrinsic value, competitors valuation, and company profile.
DCF Valuation
MEM stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MEM stock valuation using valuation multiples.
Wall Street Estimates
MEM price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MEM stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 283,100+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.